Clinical Trial Update: Pre-vitrectomy Intravitreal Ranibizumab for Patients With Proliferative Diabetic Retinopathy Combined With Diabetic Macular Edema [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating pre-vitrectomy intravitreal ranibizumab in patients with proliferative diabetic retinopathy and diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Proliferative Diabetic Retinopathy

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Proliferative Diabetic Retinopathy, Diabetic Macular Edema | Phase 4 | Status: UNKNOWN